My belief is that this first announcement is a ‘taster’
They needed something to get it all back on track.
C19 effectiveness may be with us very soon and as BMD opines could ( maybe should) get the valuation going. Today we have perhaps a nominal 5% of the capital moved, though probably much less but many times (smiley face) so far!
Looking for C19 next and extension then of today into numbers
Show me the BP that will be satisfied with splitting the spoils with another.
Back to earth however
Alls good
So far.
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV, page-87
-
- There are more pages in this discussion • 211 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
